首页> 外文期刊>European journal of human genetics: EJHG >Smith-Lemli-Opitz syndrome: evidence of T93M as a common mutation of delta7-sterol reductase in Italy and report of three novel mutations.
【24h】

Smith-Lemli-Opitz syndrome: evidence of T93M as a common mutation of delta7-sterol reductase in Italy and report of three novel mutations.

机译:Smith-Lemli-Opitz综合征:T93M是意大利delta7-甾醇还原酶的常见突变的证据,并报告了三个新突变。

获取原文
获取原文并翻译 | 示例
           

摘要

The Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder of cholesterol biosynthesis characterised by facial dysmorphisms, mental retardation and multiple congenital anomalies. SLOS is caused by mutations of the human Delta7-sterol reductase (DHCR7) gene and, so far, 19 different mutations have been described. Among these, mutations impairing the activity of the C-terminus appear to be the most severe. Here we report the mutational analysis of the DHCR7 gene in nine Italian SLOS patients. The T93M mutation, previously reported in one patient, results the most frequent one (7/18 alleles) in our survey. Furthermore, we identified three novel mutations, two missense mutations (N407Y and E448K), and a 33 bp deletion spanning part of exon 5 and the donor splice site of intron 5.
机译:Smith-Lemli-Opitz综合征(SLOS)是胆固醇生物合成的常染色体隐性遗传疾病,其特征是面部畸形,智力低下和多种先天性异常。 SLOS是由人Delta7-固醇还原酶(DHCR7)基因的突变引起的,到目前为止,已经描述了19种不同的突变。其中,损害C末端活性的突变似乎是最严重的。在这里,我们报告了9名意大利SLOS患者中DHCR7基因的突变分析。先前在一名患者中报告过的T93M突变是我们调查中频率最高的一个(7/18等位基因)。此外,我们确定了三个新突变,两个错义突变(N407Y和E448K),以及一个33 bp的缺失,跨越外显子5的一部分和内含子5的供体剪接位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号